कृपया अन्य खोज का प्रयास करें
चिन्ह | एक्सचेंज | करेंसी | ||
---|---|---|---|---|
IGXT | OTC Markets | USD | देरी | |
IGX | टोरंटो | CAD | देरी | |
IGX | CBOE कनाडा | CAD | रियल टाइम | |
0IL | फ़्रंकफ़र्ट | EUR | देरी |
IntelGenx Technologies Corp., a drug delivery company, focuses on the development and manufacturing of novel oral thin film products for the pharmaceutical market. It offers INT0008/2008, a Rizatriptan oral film product for the treatment of migraine; INT0046/2018 and INT0055/2021 are for adult use; INT0007/2006, an oral film product for treatment of erectile dysfunction; INT0043/2015, an oral film containing montelukast for treatment of Alzheimer and Parkinsons; INT0027/2011 to treat opioid addition; INT0010/2006 for treatment of neuropathic pain and nausea in cancer patients undergoing chemotherapy; INT0036/2013, an oral film product for schizophrenia or bipolar 1 disorder; and INT0048/2020 for animal health. It is also develops INT0039/2013 for pain; and INT0053/2020 for the treatment of resistant depression. The company has licensing, development, and supply agreement with Tilray, Inc.; and development agreement with Cynapsus Therapeutics Inc. IntelGenx Technologies Corp. was founded in 2003 and is headquartered in Montreal, Canada.
नाम | आयु | पहले | शीर्षक |
---|---|---|---|
Horst G. Zerbe | 76 | 2006 | Chairman & Chairman of Scientific Advisory Board |
Ryan Barrett | 43 | 2023 | Director |
Sahil V. Kirpekar | 38 | 2023 | Director |
Bernd J. Melchers | 73 | 2009 | Independent Director |
Barry D. Greenberg | - | 2016 | Member of Scientific Advisory Board |
Ludwig Aigner | - | 2016 | Member of Scientific Advisory Board |
Mark H. Nawacki | 55 | 2016 | Independent Vice Chairman |
Clemens Mayr | 55 | 2015 | Director |
Nadine Paiement | 47 | 2005 | Vice-Chair of Scientific Advisory Board and VP of Research & Development - IntelGenx Corp |
Serge Gauthier | - | - | Member of Scientific Advisory Board |
Monika Trzcinska | 57 | 2022 | Independent Director |
क्या आप सच में %USER_NAME% को ब्लॉक करना चाहते हैं?
ऐसा करके, आप और %USER_NAME% नहीं देख पाएंगे किसी अन्य के Investing.com की पोस्ट में से कोई भी।
%USER_NAME% को सफलतापूर्वक आपकी ब्लॉक सूची में जोड़ लिया गया है
क्योंकि आपने इस व्यक्ति को अनब्लॉक कर दिया है, आपको ब्लॉक को रिन्यू करने से पहले 48 घंटे प्रतीक्षा करनी होगी।
मुझे लगता है कि यह टिपण्णी:
धन्यवाद!
आपकी रिपोर्ट समीक्षा के लिए हमारे मॉडरेटर को भेजी गई है